MARKET

PACB

PACB

Pacific Biosc
NASDAQ
11.08
+0.33
+3.07%
Pre Market: 11.08 0 0.00% 08:00 12/02 EST
OPEN
10.73
PREV CLOSE
10.75
HIGH
11.29
LOW
10.49
VOLUME
148
TURNOVER
--
52 WEEK HIGH
23.69
52 WEEK LOW
3.850
MARKET CAP
2.51B
P/E (TTM)
-8.2662
1D
5D
1M
3M
1Y
5Y
Canaccord Genuity Maintains Buy on Pacific Biosciences, Raises Price Target to $14
Benzinga · 11/16 14:16
--Canaccord Genuity Ups Price Target on Pacific Biosciences to $14 From $12, Reiterates Buy Rating
--Canaccord Genuity Ups Price Target on Pacific Biosciences to $14 From $12, Reiterates Buy Rating
MT Newswires · 11/16 10:12
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Benzinga · 11/16 10:01
Sea, UiPath, J&J Snack Foods And Other Big Gainers From Tuesday
Benzinga · 11/16 07:33
PacBio to Present at Upcoming Investor Conferences
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the following upcoming investor conferences:
PR Newswire · 11/11 21:05
Invitae, Pacific Biosciences up, respectively, 39% and 21% as markets surge
Seekingalpha · 11/10 19:13
PacBio beats on bottom line in Q3 even as net loss widens 8% YoY
Seekingalpha · 11/07 23:44
BRIEF-Pacific Biosciences Of California Inc Reports Q3 Adjusted Loss Per Share Of $0.32
Reuters · 11/07 23:06
More
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed its Single Molecule, Real-Time (SMRT) technology, which enables single molecule, real-time detection of nucleic acid sequences, to address many of the limitations of previous sequencing technologies. The Company’s products include Sequel, Sequel II and Sequel IIe instruments and SMRT Cell 8M, which together can sequence up to approximately eight million deoxyribonucleic acid (DNA) molecules simultaneously, and the previous generation Sequel instrument and Sequel SMRT Cell 1M, which together conduct, monitor, and analyze single molecule biochemical reactions in real time. The Company's Sequel IIe System increases computational capacity and is designed to enable customers to generate PacBio HiFi reads.

Webull offers kinds of Pacific Biosciences of California Inc stock information, including NASDAQ:PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PACB stock methods without spending real money on the virtual paper trading platform.